GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)

Published: 4 Feb-2004

DOI: 10.3833/pdr.v2004.i44.828     ISSN: 1756-7874

Section: Research & Development



GlaxoSmithKline formed a 5 year research and development alliance with NeuroSearch for several research programs for treating CNS diseases such as depression, anxiety and schizophrenia in a deal worth up to €82 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details